| Issue Date | Title | Author(s) |
| 20-May-2021 | The genomic and transcriptomic characteristics of early recurrence patients in stage IA non-small cell lung cancer. | Zhang, Shirong; Jiang, Hong; Chen, Xueqin; Zhu, Xiuli; Bai, Jing; Wu, Qiong; Hu, Runlei; Zhu, Chenchen; Xia, Xuefeng; Xun, Yanping; Zhang, Jing; Ma, Shenglin |
| 25-Oct-2023 | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma | Chen, Xueqin; Liu, Jun; Li, Yuqin; Zeng, Yuequan; Wang, Fang; Cheng, Zexiong; Duan, Hao; Pan, Guopeng; Yang, Shangqi; Chen, Yuling; Li, Qing; Shen, Xi; Li, Ying; Qin, Zixi; Chen, Jiahong; Huang, Youwei; Wang, Xiangyu; Lu, Yuli; Shu, Minfeng; Zhang, Yubo; Wang, Guocai; Li, Kai; Lin, Xi; Xing, Fan; Zhang, Haipeng |
| 10-Oct-2023 | Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation | Huang, Youwei; Wang, Fang; Lin, Xi; Li, Qing; Lu, Yuli; Zhang, Jiayu; Shen, Xi; Tan, Jingyi; Qin, Zixi; Chen, Jiahong; Chen, Xueqin; Pan, Guopeng; Wang, Xiangyu; Zeng, Yuequan; Yang, Shangqi; Liu, Jun; Xing, Fan; Li, Kai; Zhang, Haipeng |
| 10-Oct-2023 | Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation | Huang, Youwei; Wang, Fang; Lin, Xi; Li, Qing; Lu, Yuli; Zhang, Jiayu; Shen, Xi; Tan, Jingyi; Qin, Zixi; Chen, Jiahong; Chen, Xueqin; Pan, Guopeng; Wang, Xiangyu; Zeng, Yuequan; Yang, Shangqi; Liu, Jun; Xing, Fan; Li, Kai; Zhang, Haipeng |
| 2023 | Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study | Zhang, Dongming; Liu, Xiaoyan; Shen, Fangfang; Zhao, Dahai; Shi, Yuequan; Zhang, Haoran; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Gao, Junzhen; He, Min; Liu, Yonggang; Yang, Xiaoling; Qin, Jianwen; Tang, Yuling; Mu, Xinlin; Gu, Yangchun; Zhang, Shucai; Chen, Xueqin; Pang, Li; Meng, Qingwei; Guo, Ye; Zhang, Yuhui; Li, Wei; Xing, Puyuan; Cheng, Yuan; Xin, Tao; Li, Qingxia; Li, Yu; Chen, Jun; Gao, Feng; Jin, Bo; Rossi, Antonio; Adachi, Hiroyuki; Guerrera, Francesco; Husain, Hatim; Xu, Yan; Wang, Mengzhao |
| Feb-2022 | Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial | Zhou, Caicun; Wang, Ziping; Sun, Yuping; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Chang, Jianhua; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Wang, Jingru; Li, Peiqi; Qin, Mengmeng; Lu, Dongmei; Yang, Jason |
| 28-Nov-2023 | Targeting VCP potentiates immune checkpoint therapy for colorectal cancer | Wang, Fang; Qi, Qi; Qin, Baif; Wang, Yiwei; Huang, Youwei; Li, Qing; Shen, Xi; Wang, Xiangyu; Yang, Shangqi; Pan, Guopeng; Chen, Jiahong; Qin, Zixi; Chen, Xueqin; Yang, Yuqing; Zeng, Yuequan; Liu, Jun; Li, Yuqin; Li, Ying; Cheng, Zexiong; Lin, Xi; Xing, Fan; Zhang, Yubo; Wang, Guocai; Li, Kai; Jiang, Zhenyou; Zhang, Haipeng |
